COMMUNIQUÉS West-GlobeNewswire

Basilea is awarded additional CARB-X funding to develop new drug candidate from a novel class of antibiotics

23/12/2024 - 07:15

Additional funding awarded following successful drug candidate nomination USD 7.3 million to support progression of antibiotic BAL2420 (LptA inhibitor) towards first-in-human clinical studies Ad hoc announcement [...]

MaxCyte Announces Retirement of Board Member Art Mandell

23/12/2024 - 08:00

ROCKVILLE, Md., Dec. 22, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc. , (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and [...]

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

21/12/2024 - 04:24

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness service delivering daily professional advice. This affordable platform aims to help users achieve health goals through [...]

Renovaro Regains Compliance with NASDAQ Listing Requirement

20/12/2024 - 21:40

LOS ANGELES, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB) , a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today announced that it has received a notice from the [...]

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

20/12/2024 - 22:30

NOVATO, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare [...]

Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025

20/12/2024 - 22:30

TEL AVIV, Israel, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its fourth quarter and full year 2024 financial results [...]

Publication relative à des notifications de transparence

20/12/2024 - 22:30

INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 20 décembre 2024 , 22:30h CET / 16:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative [...]

Publication relating to transparency notifications

20/12/2024 - 22:30

REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), December 20, 2024 , 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the [...]

Lexicon Announces Receipt of Complete Response Letter for Zynquista™ (sotagliflozin)

20/12/2024 - 22:30

Confirms Previously Disclosed and Anticipated FDA Decision THE WOODLANDS, Texas, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced it has received a complete response letter [...]

Procaps Group Announces Key Shareholder and Board Decisions, Committee Restructuring, and Leadership Updates

20/12/2024 - 22:53

MIAMI and BARRANQUILLA, Colombia, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today [...]

PharmAla Issues Audited Financial Statements, Completes Continuance to Ontario, and Closes Private Placement

20/12/2024 - 22:55

TORONTO, Dec. 20, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

20/12/2024 - 23:00

SAN CARLOS, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal [...]

Syntekabio to Showcase AI-Driven Drug Discovery Solutions at Biotech Showcase 2025

20/12/2024 - 19:15

NEW YORK, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Syntekabio (KOSDAQ: 226330), a leading artificial intelligence (AI)-driven drug development company, is pleased to announce its participation in Biotech Showcase 2025, taking [...]

Press Release: Sequana Medical announces results of Extraordinary General Meeting of Shareholders and update on Convertible Financing

20/12/2024 - 20:00

Sequana Medical announces results of Extraordinary General Meeting of Shareholders and update on Convertible Financing Ghent, Belgium – 20 December 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " [...]

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients as Young as 2 Years Old

20/12/2024 - 20:15

BOSTON, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases [...]

Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis

20/12/2024 - 15:15

Unique cell-impermeable 1 design extends life-saving treatment for dialysis patients Merit to host a WRAPSODY informational call on January 28, 2025 SOUTH JORDAN, Utah, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Merit Medical [...]

Quoin Pharmaceuticals Announces Pricing of $6.8 Million Public Offering

20/12/2024 - 15:20

ASHBURN, Va., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, today [...]

Compass Health Celebrates Second Donation from Longtime Partner for its State-of-the-Art Regional Center for Intensive Behavioral Health Needs

20/12/2024 - 16:00

The donation marks an end-of-year funding milestone as the non-profit enters the final stages of construction for Phase II of its Broadway Campus Redevelopment, which is set to open in summer 2025 EVERETT, Wash., Dec. [...]

HNL Lab Medicine’s Angel Tree Program Brings Holiday Magic to Families in Need

20/12/2024 - 16:06

ALLENTOWN, Pa., Dec. 20, 2024 (GLOBE NEWSWIRE) -- In the true spirit of the holidays, HNL Lab Medicine proudly celebrates the continued success of its Angel Tree initiative, now in its fourth and most impactful year. [...]